Reed Jobs's Yosemite Closes $350 Million Second Fund
Reed Jobs's Yosemite closed a $350M second cancer-focused fund, up from a $200M first close, with Amgen, AbbVie, MIT and John Doerr as LPs.
Topic
Cancer Therapeutics
Topic
Topic
Topic
Reed Jobs's Yosemite closed a $350M second cancer-focused fund, up from a $200M first close, with Amgen, AbbVie, MIT and John Doerr as LPs.